Systemic lupus erythematosus pathophysiology

Jump to navigation Jump to search

Systemic lupus erythematosus Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Systemic lupus erythematosus from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Lupus and Quality of Life

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Systemic lupus erythematosus pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Systemic lupus erythematosus pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

National Guidelines Clearinghouse

NICE Guidance

FDA on Systemic lupus erythematosus pathophysiology

on Systemic lupus erythematosus pathophysiology

Systemic lupus erythematosus pathophysiology in the news

Blogs onSystemic lupus erythematosus pathophysiology

Directions to Hospitals Treating Systemic lupus erythematosus

Risk calculators and risk factors for Systemic lupus erythematosus pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2] Raviteja Guddeti, M.B.B.S. [3]

Overview

The progression of systemic lupus erythematosus involves the immune system. There are other factors like genetic factors, hormonal abnormalities, and environmental factors that play some roles as well. The most prominent events involving immune abnormalities are related to persistent activation of B cells and plasma cells that make auto-antibodies more auto antibodies during disease progression. The most prominent events involving hormonal abnormalities are due to prolactin and estrogen. The most important environmental factors related to disease progression are ultraviolet (UV) light and some infections. On microscopic histopathological analysis, apoptotic keratinocytes, vacuolization of the basement membrane, and dermal mucin deposition are characteristic findings of SLE dermatitis, and active or inactive endocapillary or extracapillary segmental glomerulonephritis are characteristic findings of SLE nephritis.

Pathogenesis

The progression of systemic lupus erythematosus involves the immune system. Near all of the pathologic manifestation of SLE are due to antibody formation and the creation of immune complexes in different organs of the body. When the immune complexes designed, they will deposit in different body tissues and vessels, which will lead to more complement activation and more organ damage. There are other factors like genetic factors, hormonal abnormalities, and environmental factors that play some roles as well.

Immune abnormalities

Development of systemic lupus erythematosus (SLE) is the result of different mechanisms that at the end lead to auto-immune response of the body. As a result, body tissues lose their self-tolerance. Affected patients are no longer entirely tolerant to all of their self-antigens and consequently progress an autoimmune disease and develop auto antibodies as a response. During disease progression, B cells and plasma cells that make auto-antibodies are more persistently activated and thus make more auto antibodies. These auto antibodies are targeted predominantly to intracellular nucleoprotein particles 

8519610 

This increase in auto antibody production and persistence suppose to be down regulated by anti-idiotypic antibodies or regulatory immune cells, but due to immunologic response it is not appropriately been responded. 

The most important immune abnormalities that are related to SLE develop and progression: 

  • Increase in circulating plasma cells and memory B cells that is associated with SLE activity
  • Decrease in cytotoxic T cells and in functions of suppressor T cells and impaired generation of polyclonal T-cell cytolytic activity
  • Increase in helper T cells and also their function
  • Polyclonal activation of B cells and abnormal B-cell receptor signaling
  • Prolonged lives of B cells
  • Signaling abnormalities of T and B lymphocytes
    • Cellular hyperactivity
    • Hyperresponsiveness
    • May be due to genetically defects
  • Increased expression of IFN-alpha-inducible RNA transcripts by mononuclear cells that lead to elevated levels of IFN-alpha.  15593221
  • Increase in specific genetic factors expression that may be associated with autoimmunity promotion
  • Dysfunctional signaling in T and B cells that may be due to:
    • Increased calcium responses to antigen stimulation
    • Hyperphosphorylation of cytosolic protein substrates
    • Decreased nuclear factor kB
    • Abnormal voltage-gated potassium channels: These channels facilitate excessive calcium entry into T cells
  • Increased levels of microparticles (MPs):
    • Microparticles are small, membrane-bound vesicles enclose DNA, RNA, nuclear proteins, cell-adhesion molecules, growth factors, and cytokines.
    • They are shed from cells during apoptosis or activation
    • Microparticles can drive inflammation and autoimmunity by their derivatives 23672591
  • Elevated levels of circulating TNF-alpha correlate with active disease, and TNF is expressed in renal tissue in lupus nephritis
  • abnormally high levels of E-C4d and low levels of E-CR1 are characteristic of SLE, and combined measurement of the 2 molecules has high diagnostic sensitivity and specificity for lupus.
  • Increased numbers of circulating neutrophils undergoing NETosis, a form of apoptosis specific for neutrophils, releases DNA bound to protein in protein nets, which stimulates anti-DNA and IFN-alpha production
  • Increased neutrophil extracellular trap formation: 26658004
    • It may promote thrombus formation
    • It is associated with increased disease activity and renal disease and thus can be used even as a disease activity marker.
    • It can damage and kill endothelial cells and promote inflammation in atherosclerotic plaques, which may contribute to accelerated atherosclerosis in systemic lupus erythematosus
  • These changes promote the production of antinuclear antibodies

Hormonal abnormalities

The following evidence is suggestive of the hormonal predisposition of SLE:

  • Sexual predilection of females: Shows the relationship of female hormones and the onset of SLE
  • Significantly increased risk for SLE in:17393454
    • Early age of menarche
    • Early age at menopause or surgical menopause
    • Women that are treated with estrogen-containing regimens such as oral contraceptives or postmenopausal hormone replacement therapies

Hormones that are related to SLE disease progression:10503654

  • Gonadotrophins like prolactin
    • Stimulants of immune functions and is elevated in SLE
  • Exogenous estrogen - include oral contraceptive use and post-menopausal hormone replacement therapy: 10503654- 25155581
    • Stimulates the type 1 IFN pathway
    • Stimulates thymocytes, CD8+ and CD4+ T cells, B cells, macrophages, the release of certain cytokines (eg, IL-1)
    • Prompt maturation of B cells especially those that have a high affinity to ant-DNA antibodies by decreasing the apoptosis of this self-reactive B-cells 16724801
    • Stimulate expression of HLA and endothelial cell adhesion molecules (VCAM, ICAM)
    • Increases macrophage proto-oncogene expression
    • Enhanced adhesion of peripheral mononuclear cells to endothelium
  • Progesterone:
    • May inhibit the type 1 interferon pathway, suggesting that a balance between estrogen and progesterone may be critical for the body to remain healthy
    • Downregulates T-cell proliferation and increases the number of CD8 cells
  • Both progesterone and high levels of estrogen promote a Th2 response, which favors autoantibody production

Environmental factors

  • Infections can stimulates some antigen specific cells and lead to SLE disease:
    • Epstein-Barr virus (EBV): may induce anti-DNA antibodies or even lupus-like symptoms. It is associated with higher risk of SLE and also triggering the active course of disease in children
    • Trypanosomiasis or mycobacterial infections may have the same effect as EBV
    • SLE active disease flares may follow bacterial infections as well
  • Ultraviolet (UV) light: Can stimulates B-cells to produce more antibodies. It can also interfere with antigen processing by activation of macrophages and hence increase the degree of autoimmunity

Genetics

Systemic lupus erythematosus is transmitted in poly-genic inheritance pattern. Genes involved in the pathogenesis of systemic lupus erythematosus include HLA class polymorphism, complement genes, and other genes related to immunologic system as well.

The following evidence is also suggestive of the genetic predisposition of SLE:

  • Increase of disease occurrence in identical twins
  • The increase in frequency of SLE among first degree relatives
  • The increased risk of developing the disease in siblings of SLE patients
Gene class Gene subtype
HLA genes DR2, DR3, DR4, DR7, DR8, DRw12, DQw2, DQA1,

DQB1, DQ6, DQw6, DQ7, DQw7, DQw8, DQw9, B61, B8

Complement genes C2, C4, C1q
Non-HLA genes Mannose binding lectin polymorphisms

Tumour necrosis factor α

T cell receptor

Interleukin 6

CR1

Immunoglobulin Gm and Km

FcγRIIA (IgG Fc receptor)

FcγRIIIA (IgG Fc receptor)

PARP (poly-ADP ribose polymerase)

Heat shock protein 70

Humhr 3005

10768211

Homozygous deficiencies of the components of complement especially C1q are associated with developing immunologic diseases especially SLE or a lupus-like disease : 11564823 The FcγRIIA polymorphism has been associated with nephritis in African Americans and Koreans as well as Hispanic patients. Both FcgammaRIIa and FcgammaRIIIa have low binding alleles that confer risk for SLE and may act additively in the pathogenesis of disease24997134

Associated Conditions

IC deposition and subsequent complement activation in the kidney is responsible for much of the tissue damage of lupus nephritis

Gross Pathology

On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name]. Gross, enlarged very pale kidneys with flea bite or ectasia.

A good example of kidneys from a patient with nephrotic syndrome (subacute glomerulonephritis) File:Systemic lupus erythematosus 001.jpg File:Systemic lupus erythematosus 046.jpg Lupus Erythematosus Libman Sacks Embolism: Gross fixed tissue large hemorrhagic infarcts due to embolism 19yo female with known lupus and history of TIAs File:Systemic lupus erythematosus 027.jpg Lupus Erythematosus Libman Sacks Endocarditis: Gross natural color mitral valve small lesions but cause much trouble in form of TIAs and terminally multiple hemorrhagic brain infarcts File:Systemic lupus erythematosus 021.jpg Brain: Lupus Erythematosus, Systemic; Microinfarct in Cerebral Cortex File:Systemic lupus erythematosus 047.jpg Lupus Erythematosus Hepatitis: Gross natural color. A 19yo female with lupus erythematosus and hepatitis characterized by periportal cell necrosis and sinus thrombosis cause uncertain photo shows focal grid-like hyperemia File:Systemic lupus erythematosus 004.jpg

Microscopic Pathology

On microscopic histopathological analysis, apoptotic keratinocytes, vacuolization of the basement membrane, and dermal mucin deposition are characteristic findings of SLE dermatitis, and active or inactive endocapillary or extracapillary segmental glomerulonephritis are characteristic findings of SLE nephritis.

Skin histo-pathology:

Common shared histopathologic features among all different subtypes of cutaneous lupus include:

  • Hyperkeratosis
  • Epidermal atrophy
  • Dermal mucin deposition
  • Liquefactive degeneration of the basal layer of the epidermis and vacuolization
  • Thickening of the basement membrane
  • Pigment incontinence
  • Mononuclear cell infiltration at dermo-epidermal junction
  • Superficial, perivascular, and perifollicular areas (due to mononuclear cell inflammatory infiltrate)
SLE dermatitis subtype Specific microscopic findings
Acute cutaneous lupus erythematosus
  • Lymphohistiocytic infiltrate in the superficial dermis20482683
Subacute cutaneous lupus erythematosus
  • Less follicular plugging and hyperkeratosis in comparison with dischoid lupus erythematosus
  • Superficial appendageal and perivascular lymphocytic infiltration
  • Absence or minimal change of basement membrane thickening
Chronic cutaneous lupus erythematosus
  • Discoid lupus erythematosus :
    • Follicular plugging
    • Mononuclear cell infiltration near the dermal-epidermal junction, dermal blood vessels, and appendages
  • Lupus erythematosus tumidus:
    • Consisting of predominately CD3+/CD4+ lymphocytes
    • Focal interface changes
  • Lupus profundus (lupus panniculitis) :
    • Perivascular infiltrates of mononuclear cells plus panniculitis
    • Hyaline fat necrosis
    • Direct immunofluorescence: Immune deposits in the dermal-epidermal junction

Glomerulonephritis histo-pathology:

SLE nephritis subtype Light microscopy findings Electron microscopy/Immunofluorescence findings
Minimal mesangial lupus nephritis (class I) -
  • Mesangial immune deposits
Mesangial proliferative lupus nephritis (class II)
  • Mesangial hypercellularity (of any degree)
  • Mesangial matrix expansion
  • Isolated subepithelial or subendothelial deposits
Focal lupus nephritis (class III)
  • Active or inactive endocapillary or extracapillary segmental glomerulonephritis
  • Involvement of glomeruli < 50%
  • Immune deposits in the subendothelial space of the glomerular capillary and mesangium
  • Fibrinoid necrosis and crescents in glomeruli
  • Tubulointerstitial or vascular abnormalities
Diffuse lupus nephritis (class IV)
  • Endocapillary glomerulonephritis
  • Extracapillary glomerulonephritis
  • Mesangial abnormalities
  • Involvement of glomeruli > 50%
  • Subendothelial deposits specially during the active phase
  • Diffuse wire loop deposits with little or no glomerular proliferation
Lupus membranous nephropathy (class V)
  • Diffuse thickening of the glomerular capillary wall
  • Immunofluorescence or electron microscopy
  • Global or segmental subepithelial immune deposits
Advanced sclerosing lupus nephritis (class VI)
  • Global sclerosis
  • Involvement of glomeruli > 90%
  • Global or segmental subepithelial immune deposits

Synovial histopathology

  • Nonspecific histopathologic findings
  • Superficial fibrin-like material
  • Local or diffuse synovial cell lining proliferation
  • Vascular changes:
  • Perivascular mononuclear cells
  • Lumen obliteration
  • Enlarged endothelial cells
  • Thrombi

Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology

Videos

{{#ev:youtube|Tw07BFaDEo0}}

References

Template:WH Template:WS